Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Vaccine Safety"
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "COVID-19 Vaccines and Vaccination".
Deadline for manuscript submissions: closed (31 December 2022) | Viewed by 20912
Special Issue Editors
2. School of Medicine, Universidad Europea, 28670 Madrid, Spain
Interests: influenza vaccine; autoimmune inflammatory diseases; immune response
2. Department of Medicine, Universidad Europea de Madrid, Madrid, Spain
Interests: vaccination in immunosuppressed patients
Special Issue Information
We are serving as the guest editor of a special theme issue on Vaccine Safety, which will be released by Vaccines (ISSN 2076-393X) during 2022.
The pandemic we are weathering has highlighted the crucial role that vaccination has in the struggle against infections. Not only SARS CoV-2, but also other infective agents can be subjugated with proper vaccination strategies.
Besides vaccines efficacy, data about safety are crucial for Health Authorities to approve its use. After approval, physicians are the ones who should encourage their patients to follow vaccination guidelines. Sharing updated information about vaccines safety will help reassuring patients’ adherence to vaccination recommendations.
We are pleased to invite you to contribute with your work to the Special Issue on Vaccine Safety. Vaccines is an international, peer-reviewed open access journal focused on laboratory and clinical vaccine research, utilization and immunization. Our aim is to encourage scientists to publish their experimental and theoretical results in open access form.
This Special Issue aims to publish high quality reviews, regular research papers, communications and case reports on the different vaccines’ safety in general population and special groups, proposals of different schedules and its effects on vaccines’ safety, security of vaccines combined administration, effects of the vaccination programs on serotypes predominance and other aspects that may be proposed.
We look forward to receiving your contributions.
Dr. Patricia Rich
Prof. Dr. Santiago Muñoz Fernández
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- human papilloma virus
- neglected diseases